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Background: Nucleotide excision repair and the ATR-mediated DNA damage checkpoint responses are genetically
coupled.
Results: We have analyzed the basic steps of ATR activation in a biochemically defined system.
Conclusion: ATR signaling requires enlargement of the DNA excision gap by EXO1.
Significance: The six excision repair factors, ATR-ATRIP, TopBP1, and EXO1 constitute the minimum essential set of proteins
for ATR-activation upon UV-induced DNA damage.
DNA repair and DNA damage checkpoints work in concert to
help maintain genomic integrity. In vivo data suggest that these
two global responses to DNA damage are coupled. It has been
proposed that the canonical 30 nucleotide single-stranded DNA
gap generated by nucleotide excision repair is the signal that
activates the ATR-mediated DNA damage checkpoint response
and that the signal is enhanced by gap enlargement by EXO1
(exonuclease 1) 5 to 3 exonuclease activity. Here we have used
purified core nucleotide excision repair factors (RPA, XPA,
XPC, TFIIH, XPG, and XPF-ERCC1), core DNA damage check-
point proteins (ATR-ATRIP, TopBP1, RPA), and DNA dam-
aged by a UV-mimetic agent to analyze the basic steps of DNA
damage checkpoint response in a biochemically defined system.
We find that checkpoint signaling as measured by phosphory-
lation of target proteins by the ATR kinase requires enlargement
of the excision gap generated by the excision repair system by
the 5 to 3 exonuclease activity of EXO1. We conclude that, in
addition to damaged DNA, RPA, XPA, XPC, TFIIH, XPG, XPF-
ERCC1, ATR-ATRIP, TopBP1, and EXO1 constitute the mini-
mum essential set of factors for ATR-mediated DNA damage
checkpoint response.
DNA damage activates three major biochemical pathways in
eukaryotic cells: DNA repair, DNA damage checkpoints, and
apoptosis (1). The DNA damage checkpoint response delays or
arrests cell cycle progression that helps prevent the mutagenic
or lethal consequences of damage to the cell. In mammalian
organisms two main DNA damage checkpoint pathways/net-
works have been defined based on the damage-sensing kinases
that initiate the signal: the ataxia telangiectasia mutated
(ATM)4 pathway and the ATM and Rad3-related (ATR) path-
way (2). Although there is some overlap and crosstalk between
the two signaling pathways, in general, most studies support the
view that ionizing radiation and other agents that produce dou-
ble-strand breaks in DNA activate the ATM pathway, while
ultraviolet (UV) light and other genotoxic agents that generate
bulky base adducts activate the ATR-mediated checkpoint sig-
naling pathway (3). The ATM kinase is activated by recruitment
by the MRN complex to duplex termini generated by double-
strand breaks and dimer to monomer transition or during oxi-
dative stress by formation of disulfide crosslinks between the
two subunits of the ATM homodimer (4). In the case of ATR,
the signal could be the bulky adduct itself (5, 6), the stalled
replication fork (7, 8), the transcription elongation complex
stalled at the site of damage (9), the repair complex assembled
at the site of damage (10), or the canonical 30 nucleotide gap
generated by nucleotide excision repair (11–13). Although
overwhelming evidence indicates that in S phase the stalled
replication fork and the long stretches of ssDNA that result
from replication fork stalling are the primary signals for the
ATR-mediated checkpoint (14), the contributions of other
factors to checkpoint activation in G1 and G2/M are not as
well-defined (3). However, several studies have strongly sup-
ported a model whereby the canonical 30-nucleotide gap
generated by nucleotide excision repair is enlarged by EXO1,
and the enlarged single-stranded gap (presumably occupied
by RPA protein) constitutes the major signal for the ATR-
mediated checkpoint response outside of S phase (15–17).
While the in vivo data is compelling in support of the model,
there are alternative explanations for some key observations
upon which the model is based because transient knockdown of
many gene products outside the core constituents of nucleotide
excision repair have been reported to interfere with ATR-me-
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diated checkpoint signaling (14). Thus, the basic model can be
evaluated only in vitro in a system that contains components
with precisely defined function which would eliminate the in
vivo artifacts arising from mutations that affect the ATR path-
way through secondary effects on cellular homeostasis. In this
study, using highly purified minimal essential sets of both the
human nucleotide excision repair system and the ATR check-
point signaling pathway, we have reconstituted the ATR check-
point system in vitro. We find that the nucleotide excision
repair canonical 30 nucleotide gap enlarged by EXO1 is neces-
sary and sufficient to activate ATR checkpoint signaling in the
presence of the ATR co-activator TopBP1 protein. This is the
first in vitro system that couples nucleotide excision repair and
the ATR-mediated DNA damage checkpoint.
EXPERIMENTAL PROCEDURES
Protein Purification—The excision repair proteins His-XPA,
XPC-HR23B, XPG, and XPF-ERCC1 were purified as recombi-
nant proteins using the Sf21/baculovirus insect cell/vector sys-
tem as previously described (18). The multi-subunit TFIIH
complex was purified from HeLa Flp-In T-REx cells (19, 20)
expressing tetracycline-inducible FLAG-p62 as described in
the manufacturer’s directions (Invitrogen), and purified with
P11 chromatography and affinity chromatography with anti-
FLAG-M2 agarose (Sigma) as previously described (21). The
ATR-ATRIP complex was similarly purified from HeLa Flp-In
T-REx cells containing a tetracycline-inducible Flag epitope-
tagged ATRIP subunit by anti-FLAG-M2 affinity chromatogra-
phy as previously described (22). The following proteins were
purified as recombinant proteins expressed in Escherichia coli
as previously described: GST-TopBP1-His (23), EXO1 (amino
acids 1– 450) (24), GST-p53 (Addgene plasmid 10852) (25), and
RPA (26). The purified proteins were separated on 4 –15%
TGX-PAGE and analyzed by silver staining.
Cell Lines and Antibodies—Immortalized wild-type (WT)
and Exo1/ mouse embryonic fibroblasts (MEFs) were cul-
tured in DMEM containing 10% fetal bovine serum (FBS) and
penicillin/streptomycin. The Exo1/ MEFs were obtained
from Winfried Edelmann (Albert Einstein College of Medicine)
(27). To drive cells into quiescence, cells were grown in DMEM
containing 0.5% FBS for 3– 4 days. Irradiation of cells with UV
light involved the removal of the medium from the cells, expo-
sure to a UV-C light source (254 nm), and replacement of the
medium. Following a 1-h incubation, cells were washed with
cold PBS, scraped from the plate into cold PBS, and then
lysed in a buffer containing 25 mM HEPES-KOH pH 7.9, 100
mM KCl, 12 mM MgCl2, 0.5 mM EDTA, 12.5% glycerol, 1 mM
DTT, and 0.5% Nonidet P-40. Cell lysates were fractionated
by SDS-PAGE, transferred to nitrocellulose, and analyzed by
immunoblotting.
The following primary antibodies were obtained from the
indicated companies and used at the indicated dilution: from
Cell Signaling Technology, phospho-Chk1-Ser345 (catalogue
no. 2348, 1:10,000), phospho-p53-Ser15 (catalogue no. 9284,
1:10,000); from Bethyl Laboratories, RPA1 (catalogue no.
A300 –241A, 1:2,000) and phospho-RPA2-Ser33 (catalogue no.
A300 –246A, 1:10,000); from Santa Cruz Biotechnology, Inc.,
Chk1 (catalogue no. sc-8408, 1:2,000), GST (catalogue no.
sc-138, 1:1,000), and from Leica Biosystems, p53 (NCL-p53–
505, 1:1,000).
Preparation of DNA Substrates—Gapped plasmid was gener-
ated by treating pBC-KS.nick (28) with Nt.BbvCI endonuclease
which cuts only one strand of the plasmid 43 nucleotides apart.
The excised oligomer was released by heat denaturation in the
presence of excess complementary oligo. The X174 ssDNA
was purchased from New England Biolabs (N3023). N-Ace-
toxy-2-acetylaminofluorene (AAF) was obtained from the NCI
Chemical Carcinogen Repository (Midwest Research Institute,
Kansas City, MO). AAF-damaged plasmid DNA (pBC-KS.nick)
was prepared as described previously (23). The concentration
of AAF was empirically determined to generate 3 adducts per
plasmid.
Excision Repair Assay—The repair assay was performed as
previously described (18). Unmodified or AAF-damaged plas-
mid DNA (100 ng) was incubated in a 12.5-l reaction contain-
ing the core excision repair factors (XPA (86 ng), XPC-hR23B
(17.5 ng), XPF-ERCC1 (7.5 ng), XPG (4 ng), TFIIH (100 ng), and
170 ng of RPA). The final reactions contained 23 mM Hepes-
KOH (pH 7.9), 44 mM KCl, 2.5 mM MgCl2, 2 mM ATP, 2.5%
glycerol, 0.04 mM EDTA, and 0.2 mM DTT. After 90 min at
30 °C, 2.5 l of the reaction was diluted 1:4 with TE buffer and
reserved for kinase assays. To the remaining 10 l, 2 l of phe-
nol and 12 l of agarose gel-loading buffer containing TBE (0.1
M Tris, 0.1 M boric acid, 0.002 M EDTA), 1% SDS, 0.05% bro-
mphenol blue, and 10% glycerol was added and then separated
on an ethidium bromide-containing 1% agarose gel, which was
then analyzed using a Bio-Rad Molecular Imager ChemiDoc
XRS system.
Checkpoint Assay—The procedure was essentially as previ-
ously described (29). Briefly, kinase assay reactions contained
14 mM Hepes, pH 7.9, 30 mM KCl, 1 mM MgCl2, 1 mM ATP, 0.5
mM DTT, 2% glycerol, and 1 M microcystin in a 12-l final
volume. Purified ATR-ATRIP (0.2 nM), TopBP1 (2.5 nM), RPA
(100 nM), p53 (50 nM), and EXO1 (8 nM), where indicated, were
incubated in reaction buffer for 20 min at 30 °C with DNA (2
ng) as indicated. The reactions were terminated by the addition
of 3 l of 5 SDS-PAGE loading buffer (100 mM Tris, pH 6.8,
10% (v/v) glycerol, 200 mM DTT, 2% (w/v) SDS, 0.01% (w/v)
bromphenol blue) and then boiled and separated by 15% SDS-
PAGE. Phosphorylation of p53 and RPA2 were detected by
immunoblotting using the indicated phospho-specific antibod-
ies, and the level of total protein was subsequently detected by
immunoblotting the same membrane with the indicated anti-
bodies. Chemiluminescent signals were visualized with Clarity
Western blotting detection reagent (Bio-Rad) and analyzed
with the Molecular Imager ChemiDoc XRS system (Bio-Rad).
The highest phosphorylation signal on each blot was set to
100%, and the levels of phosphorylation of other samples were
expressed relative to this value. Graphed values are the average
and S.D. from at least two independent experiments.
RESULTS
Purification of Nucleotide Excision Repair and ATR Check-
point Signaling Proteins—In vitro assays with cell-free extract to
test various models for ATR-mediated checkpoint signaling are
hampered by the fact that, in humans, DNA-PK is the most
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abundant member of the PIKK family kinases (ATM, ATR,
DNA-PK) and has the most robust activity of the three kinases
(30 –33). As a consequence, it dominates the kinase activity in
cell-free extracts with any putative ATM or ATR substrates, as
there is considerable overlap among substrates of the PIKK
family (28, 34). Use of kinase inhibitors only partially alleviates
the problem (28, 34, 35). Perhaps most importantly, by using
cell-free extracts, it is not possible to define the necessary and
sufficient components of a biochemical pathway. For these rea-
sons, we have not been able to test the various models for ATR
checkpoint in cell-free extracts and found it necessary to purify
the nucleotide excision repair and checkpoint proteins that are
known to be essential for ATR-mediated checkpoint signaling.
Fig. 1 shows our highly purified nucleotide excision repair
and DNA damage checkpoint proteins. The excision repair
proteins XPA, XPC-HR23B, XPG, and XPF-ERCC1 were puri-
fied as recombinant proteins using the Sf21/baculovirus insect
cell/vector system. The multisubunit TFIIH was purified from
HeLa cells containing an inducible FLAG epitope-tagged p62
subunit through conventional chromatography steps and con-
tained some minor high molecular weight contaminants. The
identities of the main bands seen by silver staining as those
corresponding to the known TFIIH subunits were confirmed by
immunoblotting. The ATR-ATRIP complex was similarly puri-
fied from HeLa cells containing an inducible FLAG epitope-
tagged ATRIP subunit by affinity chromatography, yielding a
preparation in which the major protein bands on SDS-PAGE
are ATR and ATRIP as confirmed by immunoblotting. The
ATR co-activator, TopBP1, was purified as a recombinant pro-
tein expressed in E. coli, as were EXO1 nuclease, p53, and RPA.
A Model System for Excision Repair-Checkpoint Coupling—
Two general models have been proposed for coupling of repair
to the DNA damage checkpoint. In one, it is suggested that
either the mismatch repair protein MutS (36) or the nucleo-
tide excision repair protein XPA (10) binds to a mismatch or to
a bulky base adduct, respectively, and by some ill-defined
mechanism recruits ATR to damage sites and stimulates its
kinase activity. While these mechanisms may play some minor
roles in ATR activation, attempts to demonstrate such effects in
defined systems have not been successful. In the alternative
mechanism, it is proposed that the canonical 30-nt-long exci-
sion gap generated by nucleotide excision repair either as such
or after enlargement by exonucleases constitutes the structure/
signal that couples nucleotide excision repair to ATR-initiated
DNA damage checkpoint (11–13).
To test the model that the 30-nt-long nucleotide excision
repair-gap either as is, or after processing by EXO1 exonu-
clease, constitutes the signal for ATR checkpoint, we first used
a model DNA substrate. A plasmid DNA containing a 43-
nucleotide gap was generated by treating the plasmid with
Nt.BbvCI endonuclease, which cuts at two sites 43 nucleotides
apart in only one strand of the plasmid. The gap generated by
nicking with this enzyme followed by release of the excised
oligomer by heat denaturation was used in our reconstituted
ATR-ATRIP  TopBP1 kinase system with RPA2 (RPA32 sub-
unit of RPA) as a substrate for ATR kinase, and the results are
shown in Fig. 2A. The unprocessed gap was insufficient to acti-
vate ATR (lane 5). However, upon addition of human EXO1,
which enlarges the gap by digesting DNA in the 5 to 3 direc-
tion, resulted in ATR activation as efficiently as ssDNA (com-
pare lanes 6 and 4). Addition of EXO1 to reactions containing
circular dsDNA had no significant effect (lane 8). Thus, we
conclude that the canonical 30-nt excision gap would consti-
tute a signal for ATR kinase after enlargement with EXO1.
We and others have previously reported that Ser33 of RPA2 is
phosphorylated by ATR in a manner dependent on ssDNA in in
vitro kinase assays (37, 38). This residue of RPA2 is known to be
phosphorylated by ATR in cells treated with UV light (39).
However, it has not been reported whether RPA phosphoryla-
tion at this site occurs in a manner dependent on excision repair
and EXO1. Therefore, we examined phosphorylation of RPA2
after UV in WT and Exo1/ mouse embryonic fibroblast
(MEF) cells, and the results are shown in Fig. 2B. We find that in
quiescent cells, where UV-induced ATR activation is known to
be dependent on nucleotide excision repair (11–13, 40), that
indeed, RPA2 is phosphorylated on Ser33, and the phosphory-
lation is dependent on the presence of EXO1 (compare lanes 2
and 4). As was previously shown (15), p53 phosphorylation on
Ser18 (equivalent to Ser15 in human p53) is also dependent on
EXO1 under these conditions. Also as previously reported (13),
FIGURE 1. Purified Repair and Checkpoint Factors. Analysis of the 10 excision repair and checkpoint factors by silver staining. Approximately 5–20 ng of each
factor was subjected to 4 –15% TGX-PAGE analysis. The different subunits in the complexes are indicated by asterisks.
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in quiescent cells Chk1 protein levels are low and there is no
detectable phosphorylation at Ser345. In contrast, as expected,
in asynchronous cells where ATR activation after UV is largely
the result of replication fork stalling, phosphorylation of RPA2,
p53, and Chk1 is not dependent on EXO1 (lane 8). Thus, we
conclude that RPA2 phosphorylation on Ser33 and p53 phos-
phorylation on Ser15 are the physiologically relevant readouts
for ATR activation dependent on excision gap enlargement by
EXO1 after UV-induced DNA damage in quiescent cells, and
we set out to test this model in our defined system in vitro.
Human Nucleotide Excision Repair in Vitro and Excision Gap
Enlargement with EXO1—N-Acetoxy-2-acetylaminofluorene
(N-Aco-AAF)-damaged DNA is one of the best substrates for
nucleotide excision repair (41), and is considered to be a UV-
mimetic (42). Therefore, for our checkpoint assay we used
AAF-damaged plasmid as a substrate for the reconstituted
human excision nuclease system to generate the excision gaps
that have been proposed to initiate checkpoint signaling. First,
we tested the specificity of our reconstituted excision nuclease
system by using undamaged and AAF-modified plasmids with
the 6 core repair factors in a nicking assay for excision repair. As
seen in Fig. 3A, the purified repair factors are virtually free of
nonspecific endonucleases as evidenced by the lack of nicking
activity on undamaged DNA under conditions where on aver-
age one gap per plasmid is produced in damaged DNA (Fig. 3A,
lane 2 versus lane 4). Because it has been proposed that the
enlargement of the excision gap significantly amplifies the
checkpoint signal we tested the effect of EXO1 on the gapped
plasmid. As seen in Fig. 3B, with increasing concentration of
EXO1, the gapped plasmid band becomes more diffuse in the
agarose gel, while the band corresponding to covalently closed
DNA remains unchanged, consistent with the prediction that
EXO1 enlarges the excision repair gap. Because the excision
gap is enlarged in individual gapped molecules to varying
degrees, the “open circular” plasmid band on the agarose gel has
a diffuse appearance.
Coupling of Excision Repair with ATR Checkpoint—To test
the model of the checkpoint response to UV and UV-mimetic
agents, we treated undamaged and AAF-damaged plasmid
DNAs with various combinations of repair and checkpoint fac-
FIGURE 2. EXO1-dependent ATR Activation. A, a model system for excision repair-checkpoint coupling. ATR kinase reactions were carried out with ATR-ATRIP,
TopBP1, RPA, and EXO1 as indicated. 0.6 ng (27 pM) single-stranded X174 DNA (ssDNA), plasmid DNA (dsDNA), or gapped DNA was added to the reaction as
indicated and incubated 20 min at 30 °C. Reactions were analyzed by immunoblotting for phospho-RPA2 (Ser33) and RPA1. B, EXO1-dependent phosphory-
lation of RPA2 (Ser33) and p53 (Ser18) in quiescent cells after UV damage. Serum-starved (quiescent) or asynchronously growing (proliferating) wild-type (WT)
and Exo1/ MEFs were exposed to 20 J/m2 of UVC light and harvested 1 h later. Cell lysates were analyzed by SDS-PAGE and immunoblotting with the
indicated antibodies.
FIGURE 3. Repair factor- and damage-dependent gap generation and resection by EXO1. A, repair factor (RF)-dependent generation of gapped-DNA.
Excision reactions were performed with unmodified DNA (lanes 1 and 2) or AAF-damaged DNA (lanes 3 and 4) in the presence (lanes 2 and 4) or absence (lanes
1 and 3) of the 6 core excision repair factors (RF). The percentage of gapped DNA was quantified from identical repeats of the experiment and presented as
mean  S.D. (n  3). B, EXO1 specifically digests the gapped DNA generated by repair factors. After 90 min, excision reactions with AAF-damaged DNA without
(lanes 1–3) or with repair factors (lanes 4 – 6), EXO1 was added at the indicated concentrations for an additional 10 min before analysis by agarose gel
electrophoresis (0: lanes 1 and 4, 4 nM: lanes 2 and 5, 8 nM: lanes 3 and 6).
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tors in the absence and presence of EXO1 and tested for ATR
signaling using RPA2 phosphorylation as a readout. The results
are shown in Fig. 4. As is clear from the figure, even though a
low level signal is seen with undamaged DNA, in agreement
with earlier data (23), only the combination of AAF-DNA 
Repair Factors  ATR-ATRIP  TopBP1 resulted in strong
checkpoint signaling well above all other combinations includ-
ing signal with undamaged DNA (lane 7 versus lane 1, p  0.01),
with damaged DNA in the absence of repair factors (lane 7
versus lane 9, p  0.01), or with both damaged DNA and repair
factors but in the absence of EXO1 (lane 7 versus lane 12, p 
0.01). The low level of ATR kinase activity observed in the pres-
ence of TopBP1 and undamaged DNA (lanes 1 and 3) and with
damaged DNA in the absence of repair factors (lane 9) is con-
sistent with previous observations that under certain experi-
mental conditions DNA  TopBP1 are sufficient to cause mod-
erate checkpoint activation both in vitro (23) and in vivo (43).
DNA Concentration Effect and Kinetics of ATR Checkpoint
Signaling—Because DNA is a key component of the ATR
checkpoint pathway, we next determined the effect of DNA
concentration on excision repair  EXO1 enlargement-depen-
dent ATR checkpoint signaling. We find that under our reac-
tion conditions 4 ng DNA per reaction yields the best signal-
to-noise ratio (Fig. 5A). Next, using this amount of DNA we
carried out a time course experiment. As apparent in Fig. 5B, at
all time points the complete reaction is significantly more effec-
tive in promoting RPA2 phosphorylation by ATR than partial
reactions in which the repair factors or damaged DNA were
omitted. Taken together, these data indicate that our in vitro
system is a faithful representation of the ATR signaling system
defined genetically in yeast (3) and mammalian cells or with
partial reactions in Xenopus extracts (43).
Repair-Checkpoint Coupling as Measured by p53 Phos-
phorylation—Although RPA2 phosphorylation is a commonly
used readout for ATR checkpoint signaling in vivo and in some
studies with cell-free extracts (34, 35, 38), its significance in
delaying or arresting cell cycle progression (checkpoint
response) in G1/quiescent cells is not known. In contrast, the
phosphorylation of p53 by ATR is known to be an important
step in ATR signaling during G1 (44). Therefore, we wished to
ascertain that our in vitro repair checkpoint coupling system
was operative on p53 as well. Data shown in Fig. 6 indicate that
phosphorylation of p53 at Ser15 by ATR is dependent on dam-
aged DNA  repair factors (lane 2 versus lane 4, p  0.05). This
indicates that our in vitro system is a true representative of the
ATR checkpoint signaling pathway.
DISCUSSION
ATM and ATR Checkpoints—In humans, the two main DNA
damage checkpoint pathways are the ATM- and ATR-medi-
FIGURE 4. Repair-checkpoint coupling as measured by RPA phosphory-
lation by ATR. Kinase reactions containing 100 nM RPA as a substrate were
incubated 20 min at 30 °C. 0.2 nM ATR-ATRIP, 2.5 nM TopBP1, and 8 nM EXO1
were added, as indicated, to kinase reactions containing 4 ng unmodified
(UM) or AAF DNA from excision reactions with or without repair factors (RF) as
indicated. All six repair factors were required, as determined by omission
studies (data not shown). Reactions were analyzed by immunoblotting for
phospho-RPA2 (Ser33). The blots were also analyzed for RPA1 to control for
loading. The relative levels of phosphorylated RPA2 from identical repeats of
the experiment were quantified and presented as mean  S.D. (n  3).
FIGURE 5. DNA concentration effect and kinetics of ATR checkpoint signaling. A, titration of unmodified (UM) or AAF DNA (2, 4, or 8 ng) from excision
reactions with or without repair factors (RF) into kinase reactions containing ATR-ATRIP, TopBP1, RPA, and EXO1 as in Fig. 4. B, time course analysis of RPA2
phosphorylation in kinase reactions with 4 ng of DNA as in panel A. The graphs below show the relative levels of phosphorylated RPA2 from identical repeats
of the experiments quantified and presented as mean  S.D. (n  3).
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ated checkpoints (2). To a first approximation, the ATM check-
point response is activated by DNA double strand breaks and
the ATR checkpoint response is activated by inhibition of rep-
lication in S-phase and by UV and UV-mimetic agents that
introduce bulky base adducts in G1 and G2/M phases (1). Sub-
stantial progress has been made in mechanistic understanding
of the ATM signaling pathway. It appears that ATM is activated
by two mechanisms (4). In one, activation is initiated by double
strand breaks: The MRN complex (Mre11/Rad50/Nbs1) binds
to duplex DNA ends and unwinds the duplex by the Rad50
helicase activity to generate long stretches of single-stranded
DNA (2,000 nucleotides is optimal for activity) to which
ATM binds and undergoes dimer-to-monomer transition con-
comitant with unmasking of the ATM kinase activity on MRN
and signal transducing- and effector proteins such as the Chk2
kinase and the p53 transcription factor. In the second mode of
activation, it was reported that oxidative stress, independent of
its genotoxic effect, causes disulfide bond formation between
the ATM monomers, producing a stable dimer and in the pro-
cess induces a conformational change that activates the ATM
kinase (4).
In the case of ATR, early on it was realized that inhibition of
replication by genotoxic agents or by depletion of the dNTP
pools, both of which uncouple the activities of the replication
helicases and polymerases and result in the formation of long
stretches of ssDNA, is a potent signal for ATR activation and
therefore it was concluded that ssDNA-RPA filaments consti-
tuted the primary structure for ATR signaling (45, 46). How-
ever, other studies indicated that the ATR-mediated check-
point can be activated in G1 and G2/M phases in cells by UV
damage or by base pair mismatches, and models were proposed
for mechanisms of ATR activation in the absence of DNA rep-
lication (12, 13, 36).
Experiments in yeast, Xenopus egg extracts, and human cell
lines and cell-free systems have led to three general models for
checkpoint activation by ATR outside of S-phase: 1) Direct
Recruitment by DNA Damage. Evidence has been presented
that ATR and the 9-1-1 checkpoint clamp assemble at the site of
bulky base damage or DNA mismatches and that this assembly
of ATR-ATRIP/Rad17-RFC/9-1-1 complex on DNA activate
the ATR kinase (6). 2) Recruitment by Repair Proteins. It has
been reported that the nucleotide excision repair protein XPA
and the mismatch repair protein MSH2 bind to the respective
damage/mismatch sites and recruit ATR (Mec1 in budding
yeast) to chromatin, leading to its activation (36, 47, 48). 3)
Recruitment by the Repair Gap. Nucleotide excision repair gen-
erates a canonical 30 nucleotide gap which acts as a signal for
ATR checkpoint. There are several variants of this model. In
one, the 9-1-1 (Ddc1-Rad17-Mec3 in budding yeast) check-
point clamp is loaded onto the 5 terminus of the gap occupied
by RPA, and ATR-ATRIP (Mec1-Ddc2) is recruited to the gap
occupied by RPA through RPA-ATRIP interaction, placing
ATR in proximity of 9-1-1 and RPA-coated DNA, resulting
in ATR kinase activation (49). Presumably, TopBP1 is not
required for this mode of activation. In the second model, the
MRN complex binds to the 5 terminus of the RPA-coated exci-
sion gap; and, independent of MRN, the 9-1-1 complex is also
loaded at the 5-end of the gap; ATR-ATRIP is recruited to the
gap through ATRIP-RPA interaction (50). MRN recruits
TopBP1 to the 5-end through direct protein-protein interac-
tion. Then, TopBP1 binds to the tail of Rad9 in the 9-1-1 com-
plex causing a conformational change in TopBP1, exposing its
AAD (ATR-activating domain) which then interacts with ATR
and activates its kinase function (51, 52). In a third model, it is
proposed that enlargement of the canonical 30-nt gap by the 5
to 3 exonuclease, EXO1, both in yeast and in humans, is nec-
essary for optimal activation of ATR/Mec1 checkpoint (15–17).
In support of this model it was reported that the ATR/Mec1
checkpoint signaling was severely attenuated in EXO1 mutant
yeast or EXO1 knockdown in human cell lines. In further sup-
port of this model, it was found that in Xenopus egg extract, a
35-nt gap was only marginally capable of activating the ATR
checkpoint and that larger gaps in the range of 2000 –5000-nt
were optimal for activation (53). In support of the notion that
gaps of relatively large size are required for ATR/Mec1 check-
point activation, it has been reported that DNA damage by
agents that produce non-bulky base lesions that are mainly
repaired by base excision repair do not activate ATR/Mec1
checkpoint in G1 phase; but, when cells are defective in base
excision repair the damage is primarily repaired by nucleotide
excision repair which generates larger gaps (possibly after pro-
cessing by EXO1) activate Mec1/ATR checkpoint (54).
Minimal Essential Set of Factors for ATR Activation in the
Absence of DNA Replication—In addition to the DNA and pro-
tein components discussed here, numerous other genes have
been implicated in the ATR checkpoint response. It is beyond
the scope of this discussion to critique the data on which these
conclusions were based and what might be direct and indirect
effects of mutations affecting DNA dynamics and metabolism
on ATR activation. In vitro reconstitution experiments are nec-
essary to differentiate direct from indirect effects and to define
the ATR checkpoint at a mechanistic level.
In yeast, experiments with purified proteins led to reconsti-
tution of an in vitro system consisting of primed-DNA  RPA 
Mec1/Ddc2  Rad24-RFC/Ddc1-Rad17-Mec3 combination
with RPA and Rad53 (Chk1/Chk2 ortholog) as substrates (49).
This system closely recapitulated the Mec1 signaling pathway,
FIGURE 6. Repair-checkpoint coupling as measured by p53 phosphoryla-
tion. Kinase reactions containing p53, ATR-ATRIP, TopBP1, RPA, EXO1, and
the indicated DNA were performed as in Fig. 4. Reactions were analyzed by
immunoblotting for phospho-p53 (Ser15). The blots were also analyzed for
GST-p53 to control for loading. The relative levels of phosphorylated p53
from identical repeats of the experiment were quantified and presented as
mean  S.D. (n  2).
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but was independent of Dpb11 (TopBP1 ortholog). Dpb11 does
activate Mec1/Ddc2 in yeast (55, 56), but does not appear to
play the essential role that human TopBP1 has in ATR activa-
tion (43, 57) as it is functionally redundant with Ddc1 and Dna2
(58 – 60).
In humans, partial reconstitution reactions have been
reported with ATR-ATRIP  DNA (5); ATR-ATRIP  ssDNA 
RPA (22); and ATR-ATRIP  TopBP1  ssDNA  RPA 
Claspin with substrates that included RPA, Chk1, and p53 (23,
29, 37, 61– 64). In addition to these systems with purified pro-
teins, a number of other in vitro systems with cell-free extracts
have been reported (28, 34 –36, 65). However, because of the
limitations of cell-free extracts to unambiguously assign func-
tions to specific proteins, their utility in defining the ATR
checkpoint is also limited and therefore those systems will not
be taken into consideration in formulating a mechanistic model
for ATR checkpoint. In this report we have described a system
encompassing purified nucleotide excision repair factors, puri-
fied checkpoint proteins, an exonuclease (EXO1) that couples
the two pathways along with DNA damaged by a UV-mimetic
agent and appropriate substrates for checkpoint signaling. We
have demonstrated that the activation of the signaling pathway
is dependent on all of these components. Note, that while other
nucleases, such as E. coli EXOIII, can substitute for EXO1 (data
not shown) to generate the ssDNA to activate ATR in vitro as in
Fig. 2A, the in vivo data in Fig. 2B indicate that EXO1 is the most
physiologically relevant nuclease for gap enlargement in the
cell. Therefore, we propose that the following constitutes the
minimal essential set of factors for ATR checkpoint signaling
(Fig. 7): Signal: DNA damaged by UV or a UV-mimetic agent;
Core Excision Repair Factors: RPA, XPA, XPC, TFIIH, XPG,
XPF-ERCC1; Core ATR Checkpoint Factors: ATR-ATRIP,
TopBP1, RPA; Excision Repair-Checkpoint Coupling Factor:
EXO1. This minimal set of factors is sufficient to enable ATR to
phosphorylate RPA and p53 without the need for additional
proteins.
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